ImmunoGen Inc (NASDAQ:IMGN) People

ImmunoGen Inc

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mark Alan Goldberg
Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past)
Director · Nov 8, 2011 – Feb 12, 2024 · Past
Mark Enyedy
Other companies: Charles River Laboratories International, Inc. (Director · Since at least May 20, 2025); BioMarin Pharmaceutical Inc. (Director · Since at least Dec 27, 2023); LogicBio Therapeutics Inc (Director · Mar 17, 2020 – Nov 16, 2022 · Past); Akebia Therapeutics, Inc. (Director · Dec 12, 2018 – Jun 5, 2020 · Past); Keryx Biopharmaceuticals Inc (Director · Jun 30, 2018 – Dec 12, 2018 · Past)
CHIEF EXECUTIVE OFFICER, Director · Feb 15, 2018 – Feb 12, 2024 · Past
Stuart Arbuckle
Other companies: Praxis Precision Medicines, Inc. (Director · Since at least Jan 8, 2026); Alnylam Pharmaceuticals, Inc. (Director · Since at least Jan 5, 2026); Rhythm Pharmaceuticals, Inc. (Director · Since at least Jul 23, 2019); Vertex Pharmaceuticals Incorporated (EVP, COO · Since at least May 25, 2016); Dare Bioscience, Inc. (Director · Jun 22, 2016 – Jan 3, 2017 · Past)
Director · Jan 23, 2018 – Feb 12, 2024 · Past
Dean Mitchell
Other companies: Praxis Precision Medicines, Inc. (Chairman of the Board · Since at least Oct 15, 2020); Theravance Biopharma, Inc. (Director · Since at least Apr 30, 2019); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); Precigen, Inc. (Director · Mar 8, 2020 – Mar 14, 2024 · Past)
Director · Mar 31, 2019 – Feb 12, 2024 · Past
Nicole Onetto
Other companies: Bolt Biotherapeutics, Inc. (Director · Since at least Dec 14, 2021); Viracta Therapeutics Inc (Director · Mar 26, 2021 – Jun 9, 2022 · Past); Sunesis Pharmaceuticals Inc (Director · Sep 17, 2019 – Jun 30, 2020 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jun 11, 2019 · Past)
Director · Nov 12, 2013 – Nov 10, 2015 · Past
Isabel Kalofonos
Other companies: CG Oncology, Inc. (Chief Commercial Officer · Since at least Oct 13, 2026); Crinetics Pharmaceuticals, Inc. (Chief Commercial Officer · Since at least Dec 16, 2024)
SVP & CHIEF COMMERCIAL OFFICER · Apr 24, 2023 – Feb 12, 2024 · Past
Richard J Gregory
Other companies: ProMIS Neurosciences Inc. (Director · Jul 7, 2022 – Jul 7, 2022 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 15, 2022 · Past)
Executive VP & CSO · Jan 5, 2015 – Feb 22, 2019 · Past
Anna Berkenblit
Other companies: Surrozen, Inc. (Director · Since at least Jun 7, 2022)
SVP & CHIEF MEDICAL OFFICER · May 20, 2022 – Jun 30, 2023 · Past
David Brannon Johnston
Other companies: AVEO Pharmaceuticals Inc (Chief Financial Officer · Mar 11, 2010 – Oct 2, 2013 · Past)
Chief Financial Officer · Dec 30, 2013 – Jun 6, 2018 · Past
Stacy Ann Coen
Other companies: FibroBiologics, Inc. (Director · Since at least Jan 24, 2024)
SVP & CHIEF BUSINESS OFFICER · May 20, 2022 – Feb 12, 2024 · Past
Stephen C McCluski
Other companies: Monro, Inc. (Director · Since at least Aug 6, 2021)
Director · Jun 16, 2021 – Feb 12, 2024 · Past
Suzanne Cadden
Other companies: Novelion Therapeutics Inc (SVP, Development · Sep 14, 2011 – Sep 14, 2011 · Past)
VP, Regulatory & Quality · Dec 17, 2009 – Dec 17, 2009 · Past
Craig BarrowsExecutive VP, General Counsel · Jul 20, 2012 – Feb 24, 2020 · Past
David G FosterV.P.-Fin., Prin. Acctg. Off. · Sep 13, 2018 – Dec 31, 2020 · Past
John TagliamonteVP, Business Development · Nov 27, 2007 – Jun 11, 2008 · Past